Tag

Immunicum

Immunicum completes Phase Ib portion of ILIAD study

December 3, 2021

Immunicum has announced the completion …

Immunicum and PCI Biotech extend their collaboration

November 30, 2021

Immunicum and PCI Biotech Holding …

Immunicum recruits new Chief Financial Officer

October 28, 2021

Immunicum has announced the appointment …

Immunicum receives Advanced Therapy Medicinal Product classification

July 1, 2021

The company has received Advanced …

#D illustration of ovarian cancer

First patient enrolled in Immunicum’s ALISON study

June 23, 2021

The Phase I clinical study …

Alex Karlsson Parra

Immunicum enters research collaboration

April 14, 2021

Immunicum has announced the initiation …

Board

Immunicum announces updated executive management team

March 16, 2021

Immunicum has announced the establishment …

Jeroen Rovers

Immunicum appoints new Chief Medical Officer

March 7, 2021

Immunicum has announced that Jeroen …

Sven Rohmann Immunicum

Immunicum receives orphan drug designation

February 22, 2021

The European Medicines Agency Committee …

In a new job

Immunicum recruits new Interim CFO

February 1, 2021

Immunicum has announced that effective …

Sven Rohmann Immunicum

Immunicum receives Orphan Drug Designation

January 26, 2021

Immunicum has received Orphan Drug …

Sven Rohmann Immunicum

Immunicum completes patient recruitment for Phase Ib trial

December 21, 2020

Immunicum has announced the completion …

Sven Rohmann Immunicum

Immunicum receives Fast Track Designation

December 8, 2020

Immunicum has received Fast Track …

Sven Rohmann Immunicum

Immunicum acquires all shares in DCprime

November 19, 2020

Immunicum has entered into an …

Immunicum announces next safety and enrollment update for Phase Ib/II trial

October 6, 2020

Immunicum has announced that a …

Sven Rohmann

Immunicum announces update on corporate and clinical development strategy

October 1, 2020

Immunicum has announced an update …

1
2